Combined use of TLR4 and TLR7/8 agonists to improve the efficacy of immune checkpoint inhibitors in “hot” tumor treatment and the establishment of long-term immune protection
Preprint in Research Square (December 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Preprint in Research Square (December 2023)